Literature DB >> 21445526

Vascular adaptive responses to physical exercise and to stress are affected differently by nandrolone administration.

T Bruder-Nascimento1, S Cordellini.   

Abstract

Androgenic anabolic steroid, physical exercise and stress induce cardiovascular adaptations including increased endothelial function. The present study investigated the effects of these conditions alone and in combination on the vascular responses of male Wistar rats. Exercise was started at 8 weeks of life (60-min swimming sessions 5 days per week for 8 weeks, while carrying a 5% body-weight load). One group received nandrolone (5 mg/kg, twice per week for 8 weeks, im). Acute immobilization stress (2 h) was induced immediately before the experimental protocol. Curves for noradrenaline were obtained for thoracic aorta, with and without endothelium from sedentary and trained rats, submitted or not to stress, treated or not with nandrolone. None of the procedures altered the vascular reactivity to noradrenaline in denuded aorta. In intact aorta, stress and exercise produced vascular adaptive responses characterized by endothelium-dependent hyporeactivity to noradrenaline. These conditions in combination did not potentiate the vascular adaptive response. Exercise-induced vascular adaptive response was abolished by nandrolone. In contrast, the aortal reactivity to noradrenaline of sedentary rats and the vascular adaptive response to stress of sedentary and trained rats were not affected by nandrolone. Maximum response for 7-10 rats/group (g): sedentary 3.8 ± 0.2 vs trained 3.0 ± 0.2*; sedentary/stress 2.7 ± 0.2 vs trained/stress 3.1 ± 0.1*; sedentary/nandrolone 3.6 ± 0.1 vs trained/nandrolone 3.8 ± 0.1; sedentary/stress/nandrolone 3.2 ± 0.1 vs trained/stress/nandrolone 2.5 ± 0.1*; *P < 0.05 compared to its respective control. Stress and physical exercise determine similar vascular adaptive response involving distinct mechanisms as indicated by the observation that only the physical exercise-induced adaptive response was abolished by nandrolone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445526     DOI: 10.1590/s0100-879x2011007500043

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  6 in total

1.  Anabolic androgenic steroid-induced Takotsubo cardiomyopathy.

Authors:  Angelo Placci; Gianluigi Sella; Giancarlo Bellanti; Massimo Margheri
Journal:  BMJ Case Rep       Date:  2015-03-24

2.  Resistance training associated with the administration of anabolic-androgenic steroids improves insulin sensitivity in ovariectomized rats.

Authors:  Christiano Bertoldo Urtado; Guilherme Borges Pereira; Marilia Bertoldo Urtado; Erica Blascovi de Carvalho; Gerson Dos Santos Leite; Felipe Fedrizzi Donatto; Claudio de Oliveira Assumpção; Richard Diego Leite; Carlos Alberto da Silva; Marcelo Magalhães de Sales; Ramires Alsamir Tibana; Silvia Cristina Crepaldi Alves; Jonato Prestes
Journal:  Diabetes Metab Syndr Obes       Date:  2011-11-22       Impact factor: 3.168

3.  Nandrolone Plus Moderate Exercise Increases the Susceptibility to Lethal Arrhythmias.

Authors:  Hamideh Ghorbani Baravati; Siyavash Joukar; Hossein Fathpour; Zeinab Kordestani
Journal:  Res Cardiovasc Med       Date:  2015-05-23

4.  Effects of exercise training on stress-induced vascular reactivity alterations: role of nitric oxide and prostanoids.

Authors:  Thiago Bruder-Nascimento; Samuel T Silva; Patrícia A Boer; Sandra Cordellini
Journal:  Braz J Phys Ther       Date:  2015-06-12       Impact factor: 3.377

5.  Exercise and its interactions with various aspects of man and animal lives.

Authors:  Ariane Maris Gomes; Mauricio Rocha-E-Silva
Journal:  Acta Ortop Bras       Date:  2012-12       Impact factor: 0.513

6.  Chronic stress improves NO- and Ca2+ flux-dependent vascular function: a pharmacological study.

Authors:  Thiago Bruder-Nascimento; Dijon Henrique Salome Campos; Antônio Carlose Cicogna; Sandra Cordellini
Journal:  Arq Bras Cardiol       Date:  2015-01-23       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.